FDA Inspection
Akron General Medical Center IRRBAkron General Medical Center IRRB – FDA Inspection, Nov 7, 2013
Record Details
This FDA Inspection record concerns Akron General Medical Center IRRB, with an inspection on November 7, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 7, 2013
- Product Type
- Drugs
View Company Profile
ID · 08470eef-8b8e-41ba-a0a6-4d0637a180f9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 854419
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 56.115(a)(5)List of members
- 21 CFR 56.115(a)(2)Minutes of IRB meetings
- 21 CFR 56.111(c)Children as subjects
- 21 CFR 56.108(a)(1)Initial and continuing reviews
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Akron General Medical Center IRRB
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 22, 2026 | Not classified | Cincinnati District Office | |
| July 13, 2017 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for Akron General Medical Center IRRB
- FDA Inspection 1300420 - 2026-01-22
- FDA Inspection 1018321 - 2017-07-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.